MAS1LP1

Across TCGA pan-cancer cohorts, MAS1LP1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MAS1LP1 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MAS1LP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MAS1LP1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LIHC show a favorable association.

THCA, ESCA, and COAD are the cancer types where MAS1LP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	IV	0.630	0.972	<.001	48	view →
ESCA	OS	Tertile	All	0.751	0.458	.005	45	view →
COAD	OS	Tertile	All	0.714	0.880	.005	39	view →
LIHC	DFS	Tertile	III,IV	1.000	0.284	.016	36	view →
BLCA	DFS	Tertile	All	0.522	0.644	.027	27	view →
SKCM	OS	Tertile	II,III,IV	0.953	0.691	.009	21	view →
UCS	DFS	Tertile	II,III,IV	0.177	0.461	.036	18	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
BRCA	OS	Tertile	III,IV	0.900	0.796	.028	16	view →
LUSC	OS	Quartile	III,IV	0.151	0.769	<.001	12	view →
LGG	OS	Tertile	All	0.690	0.897	.004	12	view →
GBM	DFS	Tertile	All	0.074	0.292	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MAS1LP1–THCA (OS)

Open the THCA breakdown →